Study in Neurology Clinical Practice links anti-acidity meds (PPIs, H2RAs) to increased migraine risk in headache sufferers.

A study in Neurology Clinical Practice links anti-acidity meds, like PPIs (70% higher risk) and H2RAs (40% higher risk), to increased migraine risk in individuals already experiencing headaches. Dr. Sudhir Kumar of Indraprastha Apollo Hospitals suggests considering stopping these meds if experiencing migraines. Further research is needed to establish a definitive cause-and-effect relationship.